Lymph node (LN) stromal cells, particularly fibroblastic reticular cells (FRCs), provide critical structural support and regulate immunity, tolerance and the transport properties of LNs. For many tumors, metastasis to the LNs is predictive of poor prognosis. However, the stromal contribution to the evolving microenvironment of tumor-draining LNs (TDLNs) remains poorly understood.
LNs form an integral part of the immune system, acting as 'filters' to survey potential lymph-borne pathogens and as immunological hubs that maintain homeostasis or elicit effective immune responses. For these functions to be enabled, LNs are organized into discrete cellular compartments to which the supporting stromal cells are central [1] [2] [3] .
Lymph draining from peripheral tissues enters into LNs via afferent lymphatic vessels and along the subcapsular sinus 4 , but small constituents such as chemokines and soluble antigens under 70 kilodaltons (kDa) in size cross the sinus floor and penetrate deeper into the LN, along narrow conduits formed by FRCs [5] [6] [7] . While this conduit network provides structural support 4 , FRCs have additional properties vital for LN function. They produce various cues that are critical for the migration and localization of immune cells, such as the chemokines CCL19 and CCL21 (ref. 8) , whose receptor (CCR7) is present on naive T cells, B cells and dendritic cells (DCs) 9 . Gradients of these chemokines direct intranodal migration during homeostasis and infection 3, 10, 11 and lymphocyte homing 12 and mediate interactions between T cells and DCs 8 . FRCs are a major source of IL-7, which is essential for naive T cell survival 2 . Evidence now indicates that FRCs also contribute to immunological tolerance via deletion of self-reactive T cells [13] [14] [15] .
LNs also feature in various pathologies. Many viruses specifically target FRCs for destruction to avoid detection during infection 16 . In cancer, LNs represent the first site of metastasis 17, 18 . However, despite the increasing understanding of metastasis to LNs 19 , the mechanisms that underlie the failure of effective anti-tumor immune responses in the TDLNs remain poorly characterized. Tumor-derived factors drain to downstream LNs, bathing the cells encountered en route. Therefore, the potential exists for tumors to exploit similar communication to remotely control tissues such as the LNs to their advantage. Given the current knowledge of stromal cells in LN function, we sought to determine responses of FRCs in TDLNs. Our analysis of stromal populations demonstrated that FRCs, specifically those within TDLNs, underwent structural remodeling and transcriptional modifications that correlated with gross alterations in cellular composition and localization. Our observations indicate that aberrant stromal cues affect the downstream structure and function of TDLNs.
RESULTS Expansion and remodeling of TDLN stromal networks
To study the role of stromal cells of TDLNs before the onset of metastasis, we used a well-established B16.F10 melanoma model in which we injected B16.F10 cells into mice and assessed TDLNs over 14 d. Brachial TDLNs were significantly larger at pre-metastatic time points relative to the size of their counterparts in control mice that received PBS (non-draining lymph nodes (NDLNs)) ( Fig. 1a) . Flow cytometry confirmed that the enlargement resulted from an increase in LN cellularity over time (Fig. 1b,c and Supplementary Fig. 1a) . In contrast, NDLNs remained at a constant size (Fig. 1c) . The pre-metastatic state of TDLNs was confirmed by quantitative RT-PCR analysis of mRNA encoding melanoma markers (Tyrp1 and Dct), which was not detectable in TDLNs (Supplementary Fig. 1b) . Moreover, the enlargement and corresponding cellularity were confined to sentinel LNs, as adjacent LNs did not increase in size (Supplementary Fig. 1c) .
Stromal populations within TDLNs were identified by differential expression of the mucin-type glycoprotein podoplanin and the adhesion molecule CD31 (PECAM-1) among CD45 − cells (gating strategy, Fig. 1b) . Over the period of analysis, significant population expansion r e s o u r c e of blood endothelial cells (BECs), lymphatic endothelial cells (LECs) and FRCs was recorded specifically within TDLNs (Fig. 1d ). Next we studied Tyr CreER Braf CA Pten lox mice, which develop melanoma at multiple sites following activation of a constitutively active (CA) mutant of the serine-threonine kinase BRaf (BRaf(V600E)) and deletion of a loxP-flanked allele encoding the tumor suppressor PTEN (Pten lox ), both mediated by melanocyte-specific tamoxifen-inducible Cre recombinase expressed under the control of the promoter of the gene encoding tyrosinase (Tyr CreER ). Consistent with the results obtained for B16.F10 tumors above, TDLNs from mice bearing induced tumors were also enlarged ( Fig. 1e) , with the enlargement supported by increased cellularity of stromal populations ( Fig. 1f and Supplementary Fig. 1d ). Proliferation of FRCs was confirmed by in vivo labeling with the thymidine analog EdU, whereas turnover of LECs and BECs remained in line with that of their NDLN counterparts ( Supplementary Fig. 1e ). In contrast, we noted a significantly higher ratio of FRCs to whole-node cells for TDLNs than for NDLNs after 11 d ((P <0.05 (two-tailed unpaired t-test); Supplementary Fig. 2a ), which led us to assess changes in the FRC network in more detail. Networks remained intact in TDLNs, with collagen I cores surrounded by matrix marked by the stromal matrix cartilage component ER-TR7 and FRCs positive for podoplanin ( Supplementary Fig. 2b-d) . 'Skeleton analysis' , however, revealed fewer branches per field of view in TDLNs than in NDLNs ( Fig. 1g) , whereas branch length (Supplementary Fig. 2e ) and the size of FRCs (data not shown) were unchanged. Furthermore, gap analysis highlighted greater distances between adjacent FRC networks in TDLNs than in NDLNs ( Fig. 1h) . Evaluation of podoplanin-lined conduits by high-power confocal laser-scanning microscopy revealed that conduit thickness was significantly greater in TDLNs than in their NDLN counterparts ( Fig. 1i) ; this also highlighted physical changes of individual conduits in TDLNs relative to their NDLN counterparts ( Fig. 1i and Supplementary Fig. 2d ). Together these data indicated that conduits of TDLNs enlarged rather than increasing in frequency; hence, increasing numbers of FRCs might have been needed to provide cellular coverage to support the growing conduit diameter.
Transcriptional modification of TDLN FRCs
Given the structural alterations reported above, we next sought to identify how FRCs of TDLNs adapt to the evolving microenvironment, as well as the consequences of such changes. We sorted FRCs from LNs at days 4 and 11 after inoculation of B16.F10 cells and subjected the FRCs to whole-genome transcriptional profiling. At day 4, tumors were barely palpable (data not shown); thus, this time point was chosen to represent an early stage of development at which communication between lymphatics and TDLNs was probably at its earliest stages. In contrast, large tumors at day 11, with established stromal and LN connections, represented the late stage of LN transformation.
Inter-replicate coefficients of variation confirmed consistency between samples, with means of 0.036 (NDLNs), 0.037 (TDLNs at day 4) and 0.035 (TDLNs at day 11). Application of a cutoff of 1.5-fold for change in expression in the gene array revealed distinct differences between FRCs from TDLNs and those from NDLNs ( Supplementary  Fig. 2f-h) . We initially calculated principal components. When plotted, eigenvalues of these showed that the majority of variance (88.9% and 4.5%, respectively) was contained within principal component 1 (PC1) and PC2 ( Supplementary Fig. 2i ), which partitioned into their respective sample types: PC1 effectively separated NDLNs and TDLNs at day 4, and PC2 separated NDLNs and TDLNs at day 11 ( Fig. 2a) .
Correlation matrix plots supported the conclusion of this relationship and showed strong association within all data sets ( Fig. 2b) .
That result was further confirmed by hierarchical clustering, which showed strong association within all data sets ( Fig. 2c) . A heat map of the data linked to hierarchical clusters revealed that clusters of samples (NDLNs, TDLNs at day 4 and TDLNs at day 11) exhibited the same pattern of gene-expression changes within their groups (Fig. 2c,  bottom) . These data demonstrated that the gene-expression profiles for TDLNs at day 4 and TDLNs at day 11 were distinct and replicable and indicated that the FRCs underwent a gradual reprogramming response after exposure to tumor factors, with day 4 representing a distinct and transitional state. Correlation npg r e s o u r c e Identification of pathways deregulated in FRCs Significant overall differences in expression of 1.5-fold were observed for the conditions (P <0.05; Supplementary Fig. 3a ). Differential gene expression between day 4 and day 11 illustrated transient increases or decreases, which probably represented early activation or repression of FRC signaling pathways. This expression either returned to control levels by 11 d or continued to be further upregulated or downregulated. While expression within the array differed over time, the number of altered genes remained similar: 106 genes were downregulated at day 4, and 81 genes were downregulated at day 11, with an overlap (i.e., genes similarly upregulated in both conditions) of 39 genes, whereas 117 genes were upregulated at day 4, and 131 genes were upregulated at day 11, with an overlap of 25 genes (Fig. 3a) . We determined the genes with the greatest deregulation between day 4 and day 11 in TDLNs relative to that in NDLNs, as ranked by their expression (Fig. 3b ). Aqp1 was among the genes most upregulated after 4 d, but by 11 d its expression returned to baseline (Fig. 3b) . In contrast, Fxyd6, Igh4, Thy1 and Ptx3 were among the genes most upregulated at day 11 (Fig. 3b) , which indicated a unique late-stage signature. Clustering of the genes with the greatest deregulation into functional groups (according to the products encoded) highlighted differences in proliferation, metabolism, mitochondrial function, movement and migration, and cell-junction pathways (Fig. 3c) . Associated gene-product functions were collated by common pathways of the products of deregulated genes in TDLNs at day 4 and TDLNs at day 11, generated by r e s o u r c e gene-set-enrichment analysis (GSEA) and Ingenuity pathway analysis (IPA) (Supplementary Fig. 3) . These data showed that as tumors developed, FRCs specifically within TDLNs responded via transcriptionally altering signaling pathways key to their activity and function. npg r e s o u r c e genes encoding signaling molecules, such as Limk2, Kras, Tgfbr2 and Src, were upregulated in TDLNs, genes encoding cytokines and chemokines, including Il19, Il7, Ccl4 and Ccl21, were downregulated in TDLNs, relative to their expression in NDLNs (Fig. 4a) . As FRCs produce the bulk of CCL21 and IL-7 (refs. 2,8,12), we verified the expression of Ccl21 and Il7 mRNA in independent sample sets by quantitative RT-PCR; this confirmed significant downregulation of these mRNAs in TDLN FRCs in both tumor models assessed (Fig. 4b) .
FRC chemokine-cytokine signaling affects immune composition
Confocal imaging further showed downregulation of CCL21 expression at the protein level ( Fig. 4c ). We measured smaller T cell areas and concurrently larger B cell follicles per TDLN relative to that of their NDLN counterparts (Supplementary Fig. 4a) , and we quantified reductions in the cellularity of CD3ε + cells by flow cytometry (Fig. 4d) . Although we measured no difference in the frequency of CD8α + T cells in TDLNs at day 4 versus day 11 (Supplementary Fig. 4b) , a significantly lower frequency of CD4 + T cells was observed in day-11 TDLNs than in NDLNs (Fig. 4e) . Within this population, the frequency of naive CD4 + CD62L + CD44 − T cells was lower in TDLNs at day 11 than in NDLNs (Fig. 4f) . This was accompanied by significantly greater frequency of memory (CD62L + CD44 + ) CD4 + T cells, activated (CD62L − CD44 + ) CD4 + T cells (Fig. 4f) and CD4 + Foxp3 + regulatory T cells ( Fig. 4g and Supplementary Fig. 4c ) in TDLNs than in NDLNs, at day 11. Moreover, we observed impaired efficiency in the hom-ing of CD4 + T cells into TDLNs at day 11 (Fig. 4h) . Upon examining the cellular architecture of TDLNs, we observed mislocalization and disorganization of major immune-cell populations. In contrast to NDLNs, in which T cell and B cell zones were clearly delineated ( Supplementary Fig. 4d, left) , TDLNs exhibited integration and loss of this margin ( Fig. 4i and Supplementary Fig. 4d, right) . We observed a transitional stage in TDLNs at day 4 ( Supplementary Fig. 4d,  middle) . Furthermore, B cells clustered around high endothelial venules (HEVs) of TDLNs (Fig. 4j) , but we measured no difference in the capacity of B cells to home to NDLNs or to day-11 TDLNs at 18 h after the adoptive transfer of splenocytes expressing green fluorescent protein (Fig. 4k) . The accumulation of B cells around HEVs specifically within TDLNs in the absence of homing defects suggested that the migration and localization of B cells was disrupted once they exited from HEVs. Moreover, consistent with the lower expression of Il7 mRNA (Fig. 4b) , in vivo labeling with EdU showed diminished proliferation of T cells and B cells in TDLNs relative to that in NDLNs (Supplementary Fig. 4e,f) .
Other factors deregulated at the mRNA level included CXCL14 (which is chemotactic to monocytes and DCs), CCL25 (which is chemotactic to DCs) and CCL7 (which is chemotactic to monocytes), all of which were upregulated in TDLNs at day 11 (Fig. 4a) . Consistent with that, following a transient dip at day 4, the number of CD11c + 2.5 −2.5 0 DCs and CD11b + macrophages (Supplementary Fig. 5a ) was significantly increased at day 11 (Supplementary Fig. 5b,c) . Together these data suggested that tumor-driven perturbation of FRC-derived guidance cues modified not only the composition but also the localization of key populations of immune cells within TDLNs.
Activation of TDLN FRCs
Fibrosis at the primary tumor 21 , mediated by hyper-activated fibroblasts (cancer-associated fibroblasts (CAFs)) recruited and educated in the local microenvironment, provides pro-tumor support 22 . We therefore sought to determine if fibroblasts of pre-metastatic TDLNs underwent similar changes. Transcriptional profiling showed expression of genes encoding typical activation markers of the Pdpn, Fn1, Cd248, Acta2, S100a4, Vim, Myl and Col families (Fig. 5a) , indicative of greater activation of FRCs in TDLNs than in their NDLN counterparts. The upregulated expression of Pdpn, S100a4, Thy1 and Cd248 was further verified with independent data sets ( Fig. 5b and Supplementary  Fig. 5d ). These trends were largely supported by the genetic model, and expression of podoplanin protein was significantly higher in TDLNs than in NDLNs of either tumor model ( Fig. 5c) . Moreover, flow cytometry showed more granularity in FRCs of TDLNs than in those of NDLNs (Fig. 5d) , indicative of increased internal complexity and corresponding activation status. To investigate the activation status further in vitro, we compared cultured FRCs treated with tumorconditioned medium (TCM) obtained from B16.F10 cells with cells treated with control conditioned medium (CCM) from non-tumor cells. Podoplanin was upregulated at the level of both mRNA (Fig. 5e ) and protein (Fig. 5f) , and treatment with TCM enhanced the capacity r e s o u r c e of FRCs to contract collagen gels ( Fig. 5g and Supplementary Fig. 5e ). Thus, exposure to tumor-derived factors at the TDLN might have pushed the FRCs toward an activated, pro-fibrotic 'CAF-like' state.
TDLN conduits allow enhanced solute transport
Profiling of TDLN FRCs also hinted at previously undocumented activity; in particular, the expression of genes encoding many channels and ion transporters was deregulated in TDLNs at day 4 or TDLNs at day 11 relative to their expression in NDLNs (Fig. 6a) . For example, Aqp1 was substantially upregulated in the FRCs of TDLNs at day 4, before undergoing downregulation by day 11 (as verified by quantitative RT-PCR; Supplementary Fig. 5f ). To investigate if changes to channels or ion transporters were able to affect fluid transport through the conduit system, we first used an FRC culture model to measure dextran passage in vitro. While we found no difference between cells treated with CCM and those treated with TCM in their transport of 10-kDa dextran, we observed significantly greater transit of 70-kDa and 500-kDa dextran following exposure to TCM (Fig. 6b) , indicative of a less-selective barrier. We analyzed the transport of dextran into size-restricted conduits in vivo in control (PBS-treated) or tumor-bearing mice. Quantification of 70-kDa dextran revealed its transport further into paracortical areas of TDLNs at day 11 (whereas ER-TR7 coverage did not change; Fig. 6c) , where it was restricted to the FRC-lined conduits (Fig. 6d,e) . In contrast, 10-kDa dextran freely entered into conduits of both NDLNs and TDLNs (Fig. 6d) . 500-kDa dextran was observed beyond the subcapsular sinus in TDLNs but was undetectable in the paracortical area (data not shown).
As a result of the altered TDLN environment, substantial changes in the cell-assembly machinery would be expected to underlie the restructuring and enlargement of the FRC networks, along with a need for enhanced interaction between FRCs and associated matrix proteins essential to the conduit. The thickened collagen cores but reduced branches that we noted ( Fig. 1g-i) suggested that the increased number of FRCs in TDLNs supported the increased diameter of the conduit. In doing so, FRCs would form contacts with a larger number of neighboring cells and encounter a greater area of neighboring cells. That hypothesis was confirmed by network analysis. Such analyses cluster sets of genes based on their products' functions and locations and highlight families of genes whose products are significantly deregulated and either are involved in the same biological pathways or are expressed together, or physically interact. In TDLNs, four significantly relevant gene groups encoding products heavily involved in cell structure, shape and extracellular matrix were interlinked ( Fig. 6f; interaction networks, Supplementary Fig. 6 ). Together with the data above showing larger diameter conduits at day 11 (Fig. 1g) , such altered transporter repertoires would indicate a perturbation of conduit capacity, whereby conduits of TDLNs were more permissive to fluid entry and transit, which would potentially enable greater penetration of soluble tumor-derived factors into deeper areas of the LN.
DISCUSSION
LNs function as a major immunological hub essential for immunological homeostasis and the generation of appropriate immune responses, yet LNs are also the first site of metastasis for many cancers that manage to avoid immune-system-mediated clearance. It is increasingly accepted that LNs receive and respond to tumor-derived signals to generate a pro-tumor niche, but how these responses manifest and what in the LN drives them remains unclear. The stromal populations of the LN not only provide structural support but also are essential for its maintenance and physiological function 1-3,6,8-12,16,23-28 .
While studies have shown that tumor-derived factors contribute to LN lymphangiogenesis [29] [30] [31] , the LN fibroblasts and FRCs and the conduit network they form have not been thoroughly investigated in the context of the tumor. Here we found that proliferation, remodeling and transcriptional reprogramming of FRCs occurred in TDLNs. That in turn affected FRC-driven chemokine signaling, trafficking events, localization of immune cells and transport, all of which have the potential to contribute to impaired function within TDLNs.
Consistent with published studies 29, 31, 32 , TDLNs enlarged and were supported by the expansion and structural reorganization of stromal compartments. Beyond gross network remodeling, FRCs specifically within TDLNs displayed strikingly altered transcriptional profiles. The expression of two FRC-derived factors key to LN function, CCL21 and IL-7, was downregulated. Perturbation of these essential guidance cues can contribute to abnormal homing, localization and survival of immune cells. It has been reported that TDLNs exhibit diminished CCL21 expression 33, 34 . Consistent with those findings, we observed smaller T cell zones in TDLNs than in NDLNs, accumulation of B cells around HEVs and loss of the B cell-T cell zone boundary, as well as frequent T cells within B cell follicles, in TDLNs. Those features are a phenocopy of plt/plt mice, in which spontaneous loss of LN-specific isoforms of CCL19 and CCL21 'translates' into fewer T cells and impaired immune responses 2, 12, 26, 35 . Our results also draw parallels with other pathological states such as infection, in which lower LN expression of CCL21 and disruption of FRC networks underpin aberrant homing and mislocalization of leukocytes to support evasion of the immune system by Salmonella species or viral particles 16, 27, 36 . Thus, we speculate that similar functional impairments to immune responses might exist in TDLNs in which FRC networks and guidance cues are disrupted. This, however, remains to be determined. Moreover, our observations about B cells are consistent with reports demonstrating accumulation of B cells in TDLNs. Although the activation status or subtypes of the B cells that occupy TDLNs remains to be determined, it is possible that they might function as regulatory B cells, which would add a further dimension to the local immunosuppressive environment. We also note that pathogen-related inflammation did not underlie our observations. First, stromal modifications were consistent in two independent melanoma models, one of which was genetically driven rather than the result of an allograft. Second, a comparison of our array with data from published results characterizing the responses of FRCs to lipopolysaccharide-mediated inflammation 20 shows that the response of the FRCs in TDLNs is tumor dependent. In particular, key factors such as CCL21 and IL-7 were inversely regulated in the two pathological settings (data not shown).
Consistent with published studies of LN stroma 37, 38 , the FRCs of TDLNs acquired a gene signature indicative of a more activated status. This gene signature in particular is reminiscent of that of fibroblasts found within the tumor microenvironment. These hyper-activated fibroblasts modulate the extracellular matrix to support a tumor and are now emerging as key immunomodulatory intermediates. Cancer-associated fibroblasts produce a host of factors that recruit populations of immune cells, including myeloid-cell-derived cells and regulatory T cells, to the tumor but also promote their polarization into a more suppressive phenotype [39] [40] [41] [42] [43] . Having observed the accumulation of similar populations in TDLNs, we cannot exclude the possibility that following sustained exposure to tumor-derived factors, the FRCs of TDLNs adopt a more CAF-like state to generate a supportive, immunosuppressive niche.
Within TDLNs, wider conduits and enhanced collagen deposition indicate increased stiffness of the node 32 , but remodeling of the collagen core might also contribute to the size-exclusion properties npg r e s o u r c e of the conduits 5,6 that in TDLNs is disrupted. That, combined with deregulated junction properties and protein pores of the FRCs lining these channels, would suggest altered integrity of the conduit network. Such changes have the potential to lead to rapid but poorly controlled delivery of tumor-derived factors, debris and antigen to the deeper areas of the LN, which would upset the functional status quo. Moreover, the process of lymphangiogenesis both in primary tumors and in connected LNs enhances the drainage capacity, and consequently these stromal populations experience enhanced fluid flux and shear stresses. Mechanical cues such as those, rather than chemical, tumor-derived signals (data not shown), might also act as a stimulus for FRC proliferation [44] [45] [46] [47] or act in synergy to drive the transcriptional reprogramming. We have not excluded this possibility in our study here, but this avenue warrants more in-depth investigation by in vitro studies in which the effects of biophysical stimuli (i.e., flow) can be isolated.
In summary, using functional assays and comparative transcriptome analysis of FRCs in NDLNs and TDLNs from multiple tumor models, we have demonstrated that FRCs immediately downstream of tumors acquired unique transcriptional programs. Together with structural remodeling, these deregulated pathways and adapted FRC traits contributed to modified composition and aberrant localization of immune cells that might ultimately translate to a more suppressive, pro-tumor environment.
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